Prostate Cancer: Radiological Imaging

  • Vicky GohEmail author
  • Giles Rottenberg
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)


Imaging plays an important role in the assessment of prostate cancer including detection, characterisation, localisation and guidance of biopsy, treatment planning, treatment response assessment and surveillance. Radiological techniques complementing clinical assessment in current practice include transrectal ultrasound (TRUS), multi-parametric magnetic resonance imaging (MRI) for locoregional disease and contrast-enhanced computed tomography (CT) for systemic disease. Whole-body MRI is also an emerging technique for metastatic disease.


  1. 1.
    NICE clinical guidelines. Prostate cancer. 2014. Accessed 8/7/2014.
  2. 2.
    Pondman KM, Fütterer JJ, ten Haken B, et al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. Eur Urol. 2008;54(3):517–27.CrossRefPubMedGoogle Scholar
  3. 3.
    Yacoub JH, Verma S, Moulton JS, Eggener S, Aytekin O. Imaging-guided prostate biopsy: conventional and emerging techniques. Radiographics. 2012;32(3):819–37.CrossRefPubMedGoogle Scholar
  4. 4.
    Poon PY, McCallum RW, Henkelman MM, et al. Magnetic resonance imaging of the prostate. Radiology. 1985;154(1):143–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746–57.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Rouviere O, Hartman RP, Lyonnet D. Prostate MR imaging at high-field strength: evolution or revolution? Eur Radiol. 2006;16(2):276–84.CrossRefPubMedGoogle Scholar
  7. 7.
    Hricak H, White S, Vigneron D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal—pelvic phased-array coils. Radiology. 1994;193(3):703–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Turkbey B, Pinto PA, Mani H, et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation. Radiology. 2010;255(1):89–99.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Delongchamps NB, Rouanne M, Flam T, et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int. 2011;107(9):1411–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Umbehr M, Bachmann LM, Held U, et al. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol. 2009;55(3):575–90.CrossRefPubMedGoogle Scholar
  11. 11.
    Donati OF, Afaq A, Vargas HA, et al. Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor gleason score. Clin Cancer Res. 2014;20(14):3705–11. [Epub ahead of print].CrossRefPubMedGoogle Scholar
  12. 12.
    Hricak H, Dooms GC, Jeffrey RB, et al. Prostatic carcinoma: staging by clinical assessment, CT and MR imaging. Radiology. 1987;162(2):331–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Cancer Imaging, Division of Imaging Sciences and Biomedical EngineeringKing’s College LondonLondonUK
  2. 2.Department of Radiology, Guy’s & St Thomas’ Hospitals NHS Foundation TrustLondonUK

Personalised recommendations